Subscribe Us

header ads

Recents

header ads

Patient Engagement Solutions Market Size, Growth, Demands Outlook and Forecasts to 2030

Precedence Research - January 27, 2023

According to the research report, the global patient engagement solutions market size is expected to touch USD 102.46  Billion by 2030, from USD 23.38 Billion in 2022, growing with a significant CAGR of 20.3% from 2022 to 2030. 

Patient Engagement Solutions Market Size 2022 to 2030

The patient engagement solutions report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global patient engagement solutions in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global patient engagement solutions market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global patient engagement solutions during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/1579

 Report Scope of the Patient Engagement Solutions Market

Report CoverageDetails
Market Size by 2030USD 102.46 Billion
Growth Rate from 2022 to 2030

CAGR of 20.3%

Base Year2021
Largest MarketNorth America
Fastest Growing MarketAsia Pacific
Forecast Period2022 to 2030
Segments CoveredDeliery Type, End User, Component, Therapeutic Area, Functionality, Region

This study covers a detailed segmentation of the global patient engagement solutions market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global patient engagement solutions market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

  • McKesson Corporation
  • Allscripts Healthcare Solutions
  • Orion Health Ltd.
  • GetWellNetwork Inc.
  • Cerner Corporation
  • Medecision Inc.
  • Phytel Inc.
  • Athenahealth Inc.
  • YourCareUniverse Inc.
  • Lincor Solutions Ltd.

Market Segmentation

 By Delivery Type

  • Web-based/Cloud-based
  • On-premise

By Component

  • Software
    • Standalone
    • Integrated
  • Services
    • Consulting
    • Implementation & Training
    • Support & Maintenance
    • Others
  • Hardware

By End Use

  • Payers
  • Providers
  • Individual Users

By Application

  • Social Management
  • Health Management
  • Home Healthcare Management
  • Financial Health Management

By Therapeutic Area

  • Chronic Diseases
  • Fitness
  • Women’s Health
  • Mental Health
  • Others

By Functionality

  • Communication
  • Health Tracking & Insights
  • Billing & Payments
  • Administrative
  • Patient Education
  • Others

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Research Methodology

The research methodology adopted by analysts for compiling the global patient engagement solutions report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global patient engagement solutions market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Functionality Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Patient Engagement Solutions Market 

5.1. COVID-19 Landscape: Patient Engagement Solutions Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Patient Engagement Solutions Market, By Delivery Type

8.1. Patient Engagement Solutions Market, by Delivery Type, 2022-2030

8.1.1. Web-based/Cloud-based

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. On-premise

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Patient Engagement Solutions Market, By Component

9.1. Patient Engagement Solutions Market, by Component Type, 2022-2030

9.1.1. Software

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Services

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Hardware

9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Patient Engagement Solutions Market, By End Use

10.1. Patient Engagement Solutions Market, by End Use Type, 2022-2030

10.1.1. Payers

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Providers

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Individual Users

10.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Patient Engagement Solutions Market, By Application

11.1. Patient Engagement Solutions Market, by Application Type, 2022-2030

11.1.1. Social Management

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Health Management

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Home Healthcare Management

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Financial Health Management

11.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Patient Engagement Solutions Market, By Therapeutic Area

12.1. Patient Engagement Solutions Market, by Therapeutic Area, 2022-2030

12.1.1. Chronic Diseases

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Fitness

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Women’s Health

12.1.3.1. Market Revenue and Forecast (2017-2030)

12.1.4. Mental Health

12.1.4.1. Market Revenue and Forecast (2017-2030)

12.1.5. Others

12.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Patient Engagement Solutions Market, By Functionality

13.1. Patient Engagement Solutions Market, by Component Type, 2022-2030

13.1.1. Communication

13.1.1.1. Market Revenue and Forecast (2017-2030)

13.1.2. Health Tracking & Insights

13.1.2.1. Market Revenue and Forecast (2017-2030)

13.1.3. Billing & Payments

13.1.3.1. Market Revenue and Forecast (2017-2030)

13.1.4. Administrative

13.1.4.1. Market Revenue and Forecast (2017-2030)

13.1.5. Patient Education

13.1.5.1. Market Revenue and Forecast (2017-2030)

13.1.6. Others

13.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 14. Global Patient Engagement Solutions  Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Delivery (2017-2030)

14.1.2. Market Revenue and Forecast, by Component (2017-2030)

14.1.3. Market Revenue and Forecast, by End Use (2017-2030)

14.1.4. Market Revenue and Forecast, by Application (2017-2030)

14.1.5. Market Revenue and Forecast, by Therapeutic Area (2017-2030)

14.1.6. Market Revenue and Forecast, by Functionality (2017-2030)

14.1.7. U.S.

14.1.7.1. Market Revenue and Forecast, by Delivery (2017-2030)

14.1.7.2. Market Revenue and Forecast, by Component (2017-2030)

14.1.7.3. Market Revenue and Forecast, by End Use (2017-2030)

14.1.7.4. Market Revenue and Forecast, by Application (2017-2030)

14.1.8. Market Revenue and Forecast, by Therapeutic Area (2017-2030)

14.1.8.1. Market Revenue and Forecast, by Functionality (2017-2030) 

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Delivery (2017-2030)

14.1.9.2. Market Revenue and Forecast, by Component (2017-2030)

14.1.9.3. Market Revenue and Forecast, by End Use (2017-2030)

14.1.9.4. Market Revenue and Forecast, by Application (2017-2030)

14.1.10. Market Revenue and Forecast, by Therapeutic Area (2017-2030)

14.1.11. Market Revenue and Forecast, by Functionality (2017-2030)

14.1.11.1.

14.2. Europe

14.2.1. Market Revenue and Forecast, by Delivery (2017-2030)

14.2.2. Market Revenue and Forecast, by Component (2017-2030)

14.2.3. Market Revenue and Forecast, by End Use (2017-2030)

14.2.4. Market Revenue and Forecast, by Application (2017-2030) 

14.2.5. Market Revenue and Forecast, by Therapeutic Area (2017-2030)

14.2.6. Market Revenue and Forecast, by Functionality (2017-2030)

14.2.7.

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Delivery (2017-2030)

14.2.8.2. Market Revenue and Forecast, by Component (2017-2030)

14.2.8.3. Market Revenue and Forecast, by End Use (2017-2030)

14.2.9. Market Revenue and Forecast, by Application (2017-2030) 

14.2.10. Market Revenue and Forecast, by Therapeutic Area (2017-2030)

14.2.10.1. Market Revenue and Forecast, by Functionality (2017-2030) 

14.2.11. Germany

14.2.11.1. Market Revenue and Forecast, by Delivery (2017-2030)

14.2.11.2. Market Revenue and Forecast, by Component (2017-2030)

14.2.11.3. Market Revenue and Forecast, by End Use (2017-2030)

14.2.12. Market Revenue and Forecast, by Application (2017-2030)

14.2.13. Market Revenue and Forecast, by Therapeutic Area (2017-2030)

14.2.14. Market Revenue and Forecast, by Functionality (2017-2030)

14.2.14.1.

14.2.15. France

14.2.15.1. Market Revenue and Forecast, by Delivery (2017-2030)

14.2.15.2. Market Revenue and Forecast, by Component (2017-2030)

14.2.15.3. Market Revenue and Forecast, by End Use (2017-2030)

14.2.15.4. Market Revenue and Forecast, by Application (2017-2030)

14.2.16. Market Revenue and Forecast, by Therapeutic Area (2017-2030)

14.2.16.1. Market Revenue and Forecast, by Functionality (2017-2030)

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Forecast, by Delivery (2017-2030)

14.2.17.2. Market Revenue and Forecast, by Component (2017-2030)

14.2.17.3. Market Revenue and Forecast, by End Use (2017-2030)

14.2.17.4. Market Revenue and Forecast, by Application (2017-2030)

14.2.18. Market Revenue and Forecast, by Therapeutic Area (2017-2030)

14.2.18.1. Market Revenue and Forecast, by Functionality (2017-2030)

14.3. APAC

14.3.1. Market Revenue and Forecast, by Delivery (2017-2030)

14.3.2. Market Revenue and Forecast, by Component (2017-2030)

14.3.3. Market Revenue and Forecast, by End Use (2017-2030)

14.3.4. Market Revenue and Forecast, by Application (2017-2030)

14.3.5. Market Revenue and Forecast, by Therapeutic Area (2017-2030)

14.3.6. Market Revenue and Forecast, by Functionality (2017-2030)

14.3.7. India

14.3.7.1. Market Revenue and Forecast, by Delivery (2017-2030)

14.3.7.2. Market Revenue and Forecast, by Component (2017-2030)

14.3.7.3. Market Revenue and Forecast, by End Use (2017-2030)

14.3.7.4. Market Revenue and Forecast, by Application (2017-2030)

14.3.8. Market Revenue and Forecast, by Therapeutic Area (2017-2030)

14.3.9. Market Revenue and Forecast, by Functionality (2017-2030)

14.3.10. China

14.3.10.1. Market Revenue and Forecast, by Delivery (2017-2030)

14.3.10.2. Market Revenue and Forecast, by Component (2017-2030)

14.3.10.3. Market Revenue and Forecast, by End Use (2017-2030)

14.3.10.4. Market Revenue and Forecast, by Application (2017-2030)

14.3.11. Market Revenue and Forecast, by Therapeutic Area (2017-2030)

14.3.11.1. Market Revenue and Forecast, by Functionality (2017-2030)

14.3.12. Japan

14.3.12.1. Market Revenue and Forecast, by Delivery (2017-2030)

14.3.12.2. Market Revenue and Forecast, by Component (2017-2030)

14.3.12.3. Market Revenue and Forecast, by End Use (2017-2030)

14.3.12.4. Market Revenue and Forecast, by Application (2017-2030)

14.3.12.5. Market Revenue and Forecast, by Therapeutic Area (2017-2030)

14.3.12.6. Market Revenue and Forecast, by Functionality (2017-2030)

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Forecast, by Delivery (2017-2030)

14.3.13.2. Market Revenue and Forecast, by Component (2017-2030)

14.3.13.3. Market Revenue and Forecast, by End Use (2017-2030)

14.3.13.4. Market Revenue and Forecast, by Application (2017-2030)

14.3.13.5. Market Revenue and Forecast, by Therapeutic Area (2017-2030)

14.3.13.6. Market Revenue and Forecast, by Functionality (2017-2030)

14.4. MEA

14.4.1. Market Revenue and Forecast, by Delivery (2017-2030)

14.4.2. Market Revenue and Forecast, by Component (2017-2030)

14.4.3. Market Revenue and Forecast, by End Use (2017-2030)

14.4.4. Market Revenue and Forecast, by Application (2017-2030)

14.4.5. Market Revenue and Forecast, by Therapeutic Area (2017-2030)

14.4.6. Market Revenue and Forecast, by Functionality (2017-2030)

14.4.7. GCC

14.4.7.1. Market Revenue and Forecast, by Delivery (2017-2030)

14.4.7.2. Market Revenue and Forecast, by Component (2017-2030)

14.4.7.3. Market Revenue and Forecast, by End Use (2017-2030)

14.4.7.4. Market Revenue and Forecast, by Application (2017-2030)

14.4.8. Market Revenue and Forecast, by Therapeutic Area (2017-2030)

14.4.9. Market Revenue and Forecast, by Functionality (2017-2030)

14.4.10. North Africa

14.4.10.1. Market Revenue and Forecast, by Delivery (2017-2030)

14.4.10.2. Market Revenue and Forecast, by Component (2017-2030)

14.4.10.3. Market Revenue and Forecast, by End Use (2017-2030)

14.4.10.4. Market Revenue and Forecast, by Application (2017-2030)

14.4.11. Market Revenue and Forecast, by Therapeutic Area (2017-2030)

14.4.12. Market Revenue and Forecast, by Functionality (2017-2030)

14.4.13. South Africa

14.4.13.1. Market Revenue and Forecast, by Delivery (2017-2030)

14.4.13.2. Market Revenue and Forecast, by Component (2017-2030)

14.4.13.3. Market Revenue and Forecast, by End Use (2017-2030)

14.4.13.4. Market Revenue and Forecast, by Application (2017-2030)

14.4.13.5. Market Revenue and Forecast, by Therapeutic Area (2017-2030)

14.4.13.6. Market Revenue and Forecast, by Functionality (2017-2030)

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Forecast, by Delivery (2017-2030)

14.4.14.2. Market Revenue and Forecast, by Component (2017-2030)

14.4.14.3. Market Revenue and Forecast, by End Use (2017-2030)

14.4.14.4. Market Revenue and Forecast, by Application (2017-2030)

14.4.14.5. Market Revenue and Forecast, by Therapeutic Area (2017-2030)

14.4.14.6. Market Revenue and Forecast, by Functionality (2017-2030)

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Delivery (2017-2030)

14.5.2. Market Revenue and Forecast, by Component (2017-2030)

14.5.3. Market Revenue and Forecast, by End Use (2017-2030)

14.5.4. Market Revenue and Forecast, by Application (2017-2030)

14.5.5. Market Revenue and Forecast, by Therapeutic Area (2017-2030)

14.5.6. Market Revenue and Forecast, by Functionality (2017-2030)

14.5.7. Brazil

14.5.7.1. Market Revenue and Forecast, by Delivery (2017-2030)

14.5.7.2. Market Revenue and Forecast, by Component (2017-2030)

14.5.7.3. Market Revenue and Forecast, by End Use (2017-2030)

14.5.7.4. Market Revenue and Forecast, by Application (2017-2030)

14.5.8. Market Revenue and Forecast, by Therapeutic Area (2017-2030)

14.5.8.1. Market Revenue and Forecast, by Functionality (2017-2030)

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Delivery (2017-2030)

14.5.9.2. Market Revenue and Forecast, by Component (2017-2030)

14.5.9.3. Market Revenue and Forecast, by End Use (2017-2030)

14.5.9.4. Market Revenue and Forecast, by Application (2017-2030)

14.5.9.5. Market Revenue and Forecast, by Therapeutic Area (2017-2030)

14.5.9.6. Market Revenue and Forecast, by Functionality (2017-2030)

Chapter 15. Company Profiles

15.1. McKesson Corporation

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Allscripts Healthcare Solutions

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Orion Health Ltd.

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. GetWellNetwork Inc.

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Cerner Corporation

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Medecision Inc.

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Phytel Inc.

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Athenahealth Inc.

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. YourCareUniverse Inc.

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Lincor Solutions Ltd.

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

 

Tags:

Post a Comment

0 Comments